Report cover image

Canada Ophthalmic Drugs Market Forecast 2023-2030

Publisher Inkwood Research
Published Nov 17, 2023
Length 159 Pages
SKU # INKR18381623

Description

Canada Ophthalmic Drugs Market Forecast 2023-2030



KEY FINDINGS

The Canada ophthalmic drugs market growth is set to project a CAGR of 7.39% during the forecast period, 2023-2030. The market growth is accredited to a growing aging population, increasing prevalence of eye disorders, and advancements in research and development.

MARKET INSIGHTS

Canadian research institutions and pharmaceutical companies actively engage in research and development endeavors aimed at discovering and creating innovative treatments for eye diseases. There is a growing emphasis on formulating personalized and precision medicine strategies tailored to meet the unique needs of individual patients. The nation boasts a robust healthcare system that provides access to specialized eye care services. Various facilities, including eye care clinics, ophthalmic hospitals, and private practices, offer an extensive range of services, spanning routine eye examinations to advanced surgical procedures.

Within Canada, Health Canada assumes the responsibility of regulating ophthalmic drugs. Manufacturers are required to comply with Good Manufacturing Practices (GMP) and meet the safety, efficacy, and quality standards established by Health Canada. The regulatory process involves a thorough evaluation of drug submissions, encompassing both new drug submissions (NDS) and abbreviated new drug submissions (ANDS) for generic products. This ensures that ophthalmic drugs fulfill the necessary criteria before being authorized for market distribution.

Nevertheless, the Canadian ophthalmology industry encounters challenges, including the high costs associated with drug development, regulatory approval processes, and limited access to specialized care in remote areas. Tackling these challenges offers opportunities for enhanced collaboration, the implementation of cost-effective solutions, and the integration of telemedicine to enhance accessibility to eye care services.

COMPETITIVE INSIGHTS

Pfizer Inc, Bausch Health Companies Inc, and Johnson & Johnson are among the prominent companies in the market.

Our report offerings include:
  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation caters to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments


      • Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Table of Contents

159 Pages
1. Research Scope & Methodology
1.1. Study Objectives
1.2. Methodology
1.3. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Country Snapshot - Canada
2.3. Country Analysis - Canada
2.4. Scope Of Study
2.5. Crisis Scenario Analysis
2.5.1. Impact Of Covid-19 On Ophthalmic Drugs Market
2.6. Major Market Findings
2.6.1. Emerging Therapies For Dry Eye Syndrome
2.6.2. Growing Demand For Combination Therapies
2.6.3. Increasing Investment In Research & Development
2.6.4. Shift Toward Over-the-counter (Otc) Products
3. Market Dynamics
3.1. Key Drivers
3.1.1. Aging Population's Susceptibility To Age-related Eye Conditions
3.1.2. Advancements In Drug Delivery Technologies
3.1.3. Rising Prevalence Of Eye Diseases And Disorders
3.1.4. Favorable Reimbursement Policies By Healthcare Systems
3.2. Key Restraints
3.2.1. Delay In Drug Approvals
3.2.2. Side Effects Related To Ophthalmic Drugs
4. Key Analytics
4.1. Key Market Trends
4.1.1. Growing Interest In Topical Ophthalmic Drugs
4.1.2. Significant Rise In Novel Ophthalmic Therapeutics Approvals
4.2. Technology Snapshot
4.2.1. Biologics
4.2.2. Cell Therapy
4.2.3. Gene Therapy
4.2.4. Drug Delivery
4.2.5. Small Molecule
4.2.6. Other Technologies
4.3. Porter's Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entrants
4.3.5. Industry Rivalry
4.4. Growth Prospect Mapping - Canada
4.5. Market Maturity Analysis
4.6. Market Concentration Analysis
4.7. Key Buying Criteria
4.8. Regulatory Framework
5. Market By Indication
5.1. Dry Eye
5.2. Glaucoma
5.3. Infection/Inflammation/Allergies
5.4. Retinal Disorder
5.4.1. Wet Age-related Macular Degeneration
5.4.2. Dry Age-related Macular Degeneration
5.4.3. Diabetic Retinopathy
5.4.4. Other Retinal Disorders
5.5. Other Indications
6. Market By Type
6.1. Prescription Drugs
6.2. Over-the-counter Drugs
7. Market By Dosage Form
7.1. Gels
7.2. Eye Solutions & Suspensions
7.3. Capsules & Tablets
7.4. Eye Drops
7.5. Ointments
8. Market By Therapeutic Class
8.1. Anti-glaucoma
8.2. Anti-infection
8.3. Anti-inflammatory
8.4. Anti-allergy
8.5. Other Therapeutic Classes
9. Market By Distribution Channel
9.1. Hospital Pharmacies
9.2. Drug Stores
9.3. Online Pharmacies
9.4. Other Distribution Channels
10. Competitive Landscape
10.1. Key Strategic Developments
10.1.1. Mergers & Acquisitions
10.1.2. Product Launches & Developments
10.1.3. Partnerships & Agreements
10.2. Company Profiles
10.2.1. Abbvie Inc
10.2.1.1. Company Overview
10.2.1.2. Products & Services
10.2.1.3. Strengths & Challenges
10.2.2. Bausch Health Companies Inc
10.2.2.1. Company Overview
10.2.2.2. Products & Services
10.2.2.3. Strengths & Challenges
10.2.3. Johnson & Johnson
10.2.3.1. Company Overview
10.2.3.2. Products & Services
10.2.3.3. Strengths & Challenges
10.2.4. Novartis Ag
10.2.4.1. Company Overview
10.2.4.2. Products & Services
10.2.4.3. Strengths & Challenges
10.2.5. Pfizer Inc
10.2.5.1. Company Overview
10.2.5.2. Products & Services
10.2.5.3. Strengths & Challenges
10.2.6. Regeneron Pharmaceuticals Inc
10.2.6.1. Company Overview
10.2.6.2. Products & Services
10.2.6.3. Strengths & Challenges
10.2.7. Santen Pharmaceutical Co Ltd
10.2.7.1. Company Overview
10.2.7.2. Products & Services
10.2.7.3. Strengths & Challenges

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us